Pancreatic Cancer Research

ResearcherShanxi Medical UniversityActive in the last 2 years

Xingren Guo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2827-5247; OpenAlex author ID A5054200569. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 3

  1. Letter re: A deep learning model for preoperative risk stratification of pancreatic ductal adenocarcinoma based on genomic predictors of liver metastasis. Co-author DOI 10.1016/j.ejca.2025.116046↗
  2. A MR-PheWAS and bidirectional Mendelian randomization study: Exploring for causal relationships of pancreatic cancer. Last author DOI 10.1097/md.0000000000040047↗
  3. Combining Gemcitabine-Loaded Macrophage-like Nanoparticles and Erlotinib for Pancreatic Cancer Therapy. Co-author DOI 10.1021/acs.molpharmaceut.0c01225↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. A Guan · 1 shared paper, 2024 · strength 0.36
  2. Yao Peng · 1 shared paper, 2025 · strength 0.33
  3. Hongqiao Cai · 1 shared paper, 2021 · strength 0.15
  4. Ruobing Wang · 1 shared paper, 2021 · strength 0.15
  5. Yahui Liu · 1 shared paper, 2021 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.